SCHEMBL3335606

SCHEMBL3335606

COc1ccc(N2C(=O)C(OCc3ccccc3)C2C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.46
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
PPARG P37231 5/20 0.45
PPARA Q07869 3/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
KCNH2 Q12809 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
HSD11B1 P28845 1/20 0.42
FABP7 O15540 1/20 0.42
FABP5 Q01469 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13302722 0.89 ALDH1A1 (0.46) SOAT1ALDH1A1LMNACYP3A4CYP2C9
SCHEMBL13801393 0.89 ALDH1A1 (0.46) SOAT1ALDH1A1LMNACYP3A4CYP2C9
SCHEMBL13302681 0.89 ALDH1A1 (0.46) SOAT1ALDH1A1LMNACYP3A4CYP2C9
SCHEMBL4185767 0.85 SOAT1 (0.46) SOAT1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13302731 0.85 SOAT1 (0.48) SOAT1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13778892 0.82 SOAT1 (0.46) SOAT1ALDH1A1LMNAMEN1KMT2A
SCHEMBL4178627 0.82 MEN1 (0.47) SOAT1ALDH1A1LMNAMEN1KMT2A
SCHEMBL4178629 0.82 SOAT1 (0.47) SOAT1ALDH1A1LMNAMEN1KMT2A
SCHEMBL4175343 0.81 SOAT1 (0.46) SOAT1ALDH1A1LMNAMEN1KMT2A
SCHEMBL4177579 0.80 SOAT1 (0.44) SOAT1ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144698-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2010-06-10 US disclosed
US-20090143351-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2009-06-04 US disclosed
US-7501404-B2 Substituted azetidinones DAIMED (US) 2009-03-10 US disclosed
EP-1871741-A2 SUBSTITUTED AZETIDINONES Daiamed, Inc. (US) 2008-01-02 EP disclosed
US-20070105832-A1 Substituted azetidinones Cadrenal Therapeutics, Inc. 2007-05-10 US disclosed
WO-2006108039-A2 SUBSTITUTED AZETIDINONES DAIAMED, INC. (US) 2006-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105832-A1 Substituted azetidinones F2R, CPA3, CFD SOAT1 3728/4885ALDH1A1 2503/4885LMNA 1127/4885
US-20100144698-A1 SUBSTITUTED AZETIDINONES F2R, CPA3, CFD SOAT1 3728/4885ALDH1A1 2503/4885LMNA 1127/4885
US-20090143351-A1 SUBSTITUTED AZETIDINONES F2R, CPA3, CFD SOAT1 3728/4885ALDH1A1 2503/4885LMNA 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.